Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.

Source:http://linkedlifedata.com/resource/pubmed/id/17047074

Cancer Res. 2006 Oct 15 66 20 10100-11

Download in:

View as

Triples

General Info

PMID
17047074